Search

Your search keyword '"Nevanlinna, Heli"' showing total 2,485 results

Search Constraints

Start Over You searched for: Author "Nevanlinna, Heli" Remove constraint Author: "Nevanlinna, Heli"
2,485 results on '"Nevanlinna, Heli"'

Search Results

1. Understanding the genetic complexity of puberty timing across the allele frequency spectrum

2. A Likelihood Ratio Approach for Utilizing Case‐Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

3. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

4. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival

5. Publisher Correction: Understanding the genetic complexity of puberty timing across the allele frequency spectrum

6. Incorporating progesterone receptor expression into the PREDICT breast prognostic model

7. NTHL1 is a recessive cancer susceptibility gene

8. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

9. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

10. PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

11. Rare germline copy number variants (CNVs) and breast cancer risk

12. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

13. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

14. Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis.

15. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.

16. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women

17. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

18. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?

19. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

20. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis.

21. The impact of coding germline variants on contralateral breast cancer risk and survival

22. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

23. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.

24. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

25. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

26. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

27. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

28. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

29. Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients

30. Rare Germline Variants in DNA Repair Genes Detected in BRCA -Negative Finnish Patients with Early-Onset Breast Cancer.

31. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk

32. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology.

33. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

34. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

35. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study

36. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study

37. Correction: Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

38. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

39. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

40. BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer

41. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk

42. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

43. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

44. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

45. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

46. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction

47. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women.

48. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration

49. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

50. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study.

Catalog

Books, media, physical & digital resources